HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Scott Plevy Selected Research

visilizumab

11/2010Anti-CD3 antibody visilizumab is not effective in patients with intravenous corticosteroid-refractory ulcerative colitis.
11/2007A phase I study of visilizumab, a humanized anti-CD3 monoclonal antibody, in severe steroid-refractory ulcerative colitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Scott Plevy Research Topics

Disease

12Crohn Disease (Crohn's Disease)
01/2022 - 06/2003
12Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2020 - 08/2003
10Ulcerative Colitis
01/2020 - 06/2004
4Inflammation (Inflammations)
12/2013 - 11/2007
3Colitis
09/2016 - 05/2004
1Clostridium Infections
01/2019
1Sepsis (Septicemia)
02/2011
1Infections
12/2010
1Heart Diseases (Heart Disease)
11/2010
1Ileitis
04/2009
1Spondylarthropathies
11/2007
1Disease Progression
05/2004
1Sunburn
08/2003
1Pyoderma Gangrenosum
08/2003
1Wounds and Injuries (Trauma)
08/2003
1Immediate Hypersensitivity
06/2003

Drug/Important Bio-Agent (IBA)

6Infliximab (Remicade)FDA Link
06/2016 - 06/2003
4Adrenal Cortex Hormones (Corticosteroids)IBA
11/2010 - 08/2003
3Pharmaceutical PreparationsIBA
10/2018 - 02/2011
3Monoclonal AntibodiesIBA
11/2010 - 06/2003
2AutoantibodiesIBA
01/2022 - 04/2009
2Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
01/2022 - 04/2009
2Biomarkers (Surrogate Marker)IBA
01/2020 - 12/2013
2Biological ProductsIBA
01/2020 - 11/2007
2AntibodiesIBA
01/2020 - 12/2010
2Proteins (Proteins, Gene)FDA Link
01/2020 - 01/2005
2Phenobarbital (Luminal)FDA Link
07/2013 - 02/2011
2AntigensIBA
07/2013 - 06/2008
2SteroidsIBA
02/2011 - 11/2007
2visilizumabIBA
11/2010 - 11/2007
2Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
04/2009 - 11/2007
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2007 - 06/2003
1Tumor Necrosis Factor InhibitorsIBA
10/2018
1golimumabFDA Link
10/2018
1Interleukin-22 (IL-22)IBA
12/2013
1Leukocyte L1 Antigen Complex (Calgranulin)IBA
12/2013
1Interleukin-10 (Interleukin 10)IBA
07/2013
1InterleukinsIBA
07/2013
1Genetic Markers (Genetic Marker)IBA
05/2013
1Immunologic Factors (Immunomodulators)IBA
08/2003
1Anti-Bacterial Agents (Antibiotics)IBA
08/2003
1Tryptases (Tryptase)IBA
06/2003
1Immunoglobulin E (IgE)IBA
06/2003

Therapy/Procedure

4Therapeutics
10/2018 - 08/2003
3Restorative Proctocolectomy
01/2019 - 05/2004
2Biological Therapy
02/2011 - 06/2004
1Fecal Microbiota Transplantation
01/2019
1Colonic Pouches (S Pouch)
06/2008
1Blood Component Removal (Apheresis)
11/2007